Denver Research Institute Inc is categorized under Medical Research in Denver, CO and active since 1997.
Denver Research Institute Inc was established in 1997, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Paul Saenger, President at the company’s single location by writing to 1055 Clermont St, Denver, Colorado CO 80220 or by phoning (303) 393-2892. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Denver Research Institute Inc |
| Contact Person: | Paul Saenger, President |
| Address: | 1055 Clermont St, Denver, Colorado 80220 |
| Phone Number: | (303) 393-2892 |
| Website Address: | denver-research.org |
| Annual Revenue (USD): | Unknown |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5419100 |
| Share This Business: |
Denver Research Institute Inc was started in 1997 to provide professional Medical Research under the SIC code 8733 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Paul Saenger, President for inquiries that concern Denver Research Institute Inc by calling the company number (303) 393-2892, as your correspondence is most welcome. Additionally, the physical location of the single location of Denver Research Institute Inc can be found at the coordinates 39.732516,-104.935144 as well as the street address 1055 Clermont St in Denver, Colorado 80220.
For its online presence, you may visit Denver Research Institute Inc’s website at denver-research.org and engage with its social media outlets through on Twitter and on Facebook.